UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000010363 |
|---|---|
| Receipt number | R000011961 |
| Scientific Title | A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer. |
| Date of disclosure of the study information | 2013/04/01 |
| Last modified on | 2019/12/18 17:08:45 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Acronym
A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Scientific Title
A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Scientific Title:Acronym
A Prospective, Single-institution Investigation of Opioid use and Survival of patients with advanced or recurrent non-small cell lung cancer.
Region
| Japan |
Condition
Condition
advanced or recurrent non-small cell lung cancer
Classification by specialty
| Pneumology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To determine whether survival after diagnosis is associated with opiod dosing and other factors.
Basic objectives2
Safety
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
how opioid influenced survival after diagnosis
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
non-small cell lung cancer
Key exclusion criteria
nothing in particular
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Hasegawa Takaaki |
Organization
Gifu municipal hospital
Division name
Department of respiratory and medical oncology
Zip code
Address
7-1 KASHIMA-CHO GIFU-SHI GIFU
TEL
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name |
Organization
Gifu municipal hospital
Division name
Department of respiratory and medical oncology
Zip code
Address
7-1 KASHIMA-CHO GIFU-SHI GIFU
TEL
Homepage URL
Sponsor or person
Institute
Gifu municipal hospital
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Main results already published
Date of protocol fixation
| 2013 | Year | 01 | Month | 30 | Day |
Date of IRB
| 2013 | Year | 01 | Month | 30 | Day |
Anticipated trial start date
| 2013 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2016 | Year | 07 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
multiple regression analysis to determine the extent to which opioid dosing or other clinical factors (the independent variables:histology, Stage, ECOG PS, Sex) are associated with time till death after diagnosis, prospective study, complete survey in a single institute.
Management information
Registered date
| 2013 | Year | 03 | Month | 29 | Day |
Last modified on
| 2019 | Year | 12 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011961
